An efficient neural screening approach rapidly identifies circuit modules governing distinct behavioral transitions in response to pathogen exposure.
Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing partners ...